Tomasz Felpel
Tomasz Felpel
Tomasz Felpel
General Partner
Tomasz Felpel has a decade of experience leading global business development for Fortune 500 companies— brings a rare blend of corporate strategy, M&A execution, and entrepreneurial insight to early-stage investing. He is a two-time founder, an active angel investor, and a Columbia Business School MBA graduate. Tomasz has
General Partner
Tomasz Felpel has a decade of experience leading global business development for Fortune 500 companies— brings a rare blend of corporate strategy, M&A execution, and entrepreneurial insight to early-stage investing. He is a two-time founder, an active angel investor, and a Columbia Business School MBA graduate. Tomasz has advised dozens of startups through Columbia’s Build Lab and Venture Capital Organisations.
Joe Park
Tomasz Felpel
Tomasz Felpel
General Partner
Joe Park is a seasoned healthcare and business leader with over 20 years of experience involving life sciences, corporate development, and venture capital. He holds a MBA from Columbia Business School. Joe played a pivotal role when Modifi Bio was acquired by Merck & Co. for 1.3B on Oct 2024.
Paul Kwak
Tomasz Felpel
Paul Kwak
General Partner
Paul Kwak is a seasoned healthcare, defense, and enterprise AI executive with over 20 years of leadership experience across life sciences, corporate development, and federal innovation. He currently serves as Senior Director of Strategic Solutions at C3 AI, where he leads enterprise AI initiatives for national security and
General Partner
Paul Kwak is a seasoned healthcare, defense, and enterprise AI executive with over 20 years of leadership experience across life sciences, corporate development, and federal innovation. He currently serves as Senior Director of Strategic Solutions at C3 AI, where he leads enterprise AI initiatives for national security and healthcare stakeholders. Prior to that, Paul led data and analytics programs at Technomics and Group W, supporting U.S. Department of Defense and federal civilian agencies.